What was corrected and how
A subsequent correction by the company to the contents of an already published filing.
First Medium-Term Management Plan 2027
Revision to the Numerical Plan for the Fiscal Year Ending May 2027 under the Medium-Term Management Plan
Net Sales ¥10,500 million / Operating profit ¥300 million
Net Sales ¥10,800 million / Operating profit ¥550 million
For the fiscal year ending May 2027, sales of domestic cosmetic products are expected to decline, but demand related to AI and data centers is expected to remain strong, and net sales are expected to remain flat. Operating profit is expected to decline from the fiscal year ended May 2026.
Performance in the fiscal year ended May 2026 improved due in part to the capture of AI-related demand, sales activities were strengthened through the reorganization of the Sales Department, and demand related to AI and data centers is expected to remain strong. The Company will strategically allocate its budget to securing personnel, market research, research and development expenses, and other purposes. The impact of the situation in the Middle East has not been incorporated into the plan because it remains uncertain and an objective outlook is difficult to establish.
| Item | Details |
|---|---|
| Disclosure subject to correction | First Medium-Term Management Plan 2027 |
| Original disclosure date | 11 July 2024 |
| Location of correction | Revision to the Numerical Plan for the Fiscal Year Ending May 2027 under the Medium-Term Management Plan |
| Details of correction | Net Sales ¥10,500 million / Operating profit ¥300 million → Net Sales ¥10,800 million / Operating profit ¥550 million（Net Sales 2.9％ / Operating profit 83.3％） |
| Reason for correction | Performance in the fiscal year ended May 2026 improved due in part to the capture of AI-related demand, sales activities were strengthened through the reorganization of the Sales Department, and demand related to AI and data centers is expected to remain strong. The Company will strategically allocate its budget to securing personnel, market research, research and development expenses, and other purposes. The impact of the situation in the Middle East has not been incorporated into the plan because it remains uncertain and an objective outlook is difficult to establish. |
| Impact on Business Performance | For the fiscal year ending May 2027, sales of domestic cosmetic products are expected to decline, but demand related to AI and data centers is expected to remain strong, and net sales are expected to remain flat. Operating profit is expected to decline from the fiscal year ended May 2026. |
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The revisions reflect the strong performance in the fiscal year ended May 2026, driven in part by the capture of AI-related demand, the strengthening of sales activities through the reorganization of the Sales Department, and the expected continued strength of demand related to AI and data centers. At the same time, operating profit is expected to decline from the actual result for the fiscal year ended May 2026 due to strategic budget allocations for securing personnel, market research, research and development expenses, and other purposes. The impact of the situation in the Middle East has not been incorporated into the plan because it remains uncertain and an objective outlook is difficult to establish.